Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Biodesix (BDSX) Return on Sales (2019 - 2025)

Biodesix's Return on Sales history spans 7 years, with the latest figure at 0.14% for Q4 2025.

  • For Q4 2025, Return on Sales rose 27.0% year-over-year to 0.14%; the TTM value through Dec 2025 reached 0.4%, up 20.0%, while the annual FY2025 figure was 0.4%, 20.0% up from the prior year.
  • Return on Sales reached 0.14% in Q4 2025 per BDSX's latest filing, up from 0.42% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 0.14% in Q4 2025 to a low of 2.38% in Q1 2022.
  • Average Return on Sales over 5 years is 1.03%, with a median of 0.81% recorded in 2023.
  • Peak YoY movement for Return on Sales: soared 172bps in 2021, then plummeted -217bps in 2022.
  • A 5-year view of Return on Sales shows it stood at 1.82% in 2021, then rose by 6bps to 1.71% in 2022, then surged by 63bps to 0.63% in 2023, then skyrocketed by 34bps to 0.41% in 2024, then surged by 66bps to 0.14% in 2025.
  • Per Business Quant, the three most recent readings for BDSX's Return on Sales are 0.14% (Q4 2025), 0.42% (Q3 2025), and 0.58% (Q2 2025).